|
Match
|
Document |
Document Title |
|
|
US20100310563 |
METHODS FOR TREATING INDUCED CELLULAR PROLIFERATIVE DISORDERS
Methods are provided for treating a subject with a cellular proliferative disorder that include administering to the subject a therapeutically effective amount of a JAK2 inhibitor and a... |
|
|
US20090263377 |
IL-32B-TARGETED DIAGNOSIS AND THERAPY
Methods for the diagnosis and treatment of IL-32β over-expressing cancers are provided. Also provided are methods for the treatment of wounds, hair loss and the promoting and/or restoration of... |
|
|
US20110039261 |
MOBILE RAPID TEST SYSTEM FOR NUCLEIC ACID ANALYSIS
A mobile rapid test system for nucleic acid analysis. A method comprising the steps of amplification of the nucleic acids by means of rapid-PCR technology, conversion of a double-stranded... |
|
|
US20060134621 |
Diagnostic test for attention deficit hyperactivity disorder
A two-pronged approach useful for diagnostic testing of ADHD is provided, comprising (1) a genetic test to determine the DRD4 genotype and (2) a test to characterize dopamine release to... |
|
|
US20110003300 |
RAPID STERILITY MICROASSAY
The present invention relates to a method for detecting a viable microorganism in a pharmaceutical composition comprising the steps of providing a filterable pharmaceutical composition; filtering... |
|
|
US20110123984 |
FAM26C POLYMORPHISMS AND USE THEREOF FOR THE DIAGNOSTIC AND TREATMENT OF LATE ONSET ALZHEIMER'S DISEASE
Provided are methods of determining the likelihood that a subject will be diagnosed with Alzheimer's disease. Also provided are isolated and purified mammalian CALHM I, CALHM2, and CALHM3... |
|
|
US20100292159 |
METHOD OF TREATMENT OR PROPHYLAXIS OF INFLAMMATORY PAIN
This invention discloses the use of angiotensin II receptor 2 (AT2 receptor) antagonists for the treatment, prophylaxis, reversal and/or symptomatic relief of inflammatory pain, including... |
|
|
US20090326416 |
DETECTING INFECTION IN REDUCED PRESSURE WOUND TREATMENT
Provided is a method of detecting infection in a wound caused by an infecting organism at a wound site. Also provided is a system for detecting an infection in a wound at a wound site.... |
|
|
US20090308324 |
DIABETES TESTS
A method for diagnosing susceptibility to diabetes in a dog, the method comprising: (a) (i) detecting in a sample from the dog the presence or absence of a genotype in any one of the following... |
|
|
US20100190689 |
COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
Disclosed are compositions and methods related to the interaction of polyCUG and polyCCUG repeat RNA and proteins that bind to these repetitive RNA sequences. Also disclosed are methods of... |
|
|
US20110014614 |
Method of profiling gene expression in a subject having an infectious disease
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20110008779 |
Method of profiling gene expression in a subject having disease
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20100322928 |
METHODS OF DIAGNOSING, MONITORING TREATMENT AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
A method of treating systemic lupus erythematosus (SLE) in a subject are provided. The method comprise altering in cells of the subject activity and/or expression of at least one gene selected... |
|
|
US20110065119 |
REVERSE PROGENY MAPPING
Provided is a method for mapping traits in organisms, in particular in plants. The method comprises a) providing a population of SDR-0 organisms, in particular plants, that each arise from one... |
|
|
US20090311683 |
COMPOSITIONS FOR THE USE IN IDENTIFICATION OF FUNGI
The present invention provides compositions, kits and methods for rapid identification and quantification of fungi by molecular mass and base composition analysis. |
|
|
US20100184798 |
Methods to Predict Cholesterol Elevations during Immunosuppressant Therapy
This invention provides methods to predict the degree of elevation of serum cholesterol levels in patients treated with immunosuppressive medication. This invention also provides treatment... |
|
|
US20060166197 |
Building block capable of transferring a functional entity
A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is... |
|
|
US20110052502 |
MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof
Methods and compositions for the diagnosis, prognosis and/or treatment of leukemia associated diseases are disclosed. |
|
|
US20080138896 |
Methods for Inhibiting Melanocyte Stem Cell Loss
The invention relates to methods and compositions useful for altering and assessing melanocyte stem cell self-maintenance. Loss of such self-maintenance results in loss of melanocyte stem cells... |
|
|
US20110046011 |
SECRETION OF PROTEINS WITH MULTIPLE DISULFIDE BONDS IN BACTERIA AND USES THEREOF
The invention provides methods for using the Twin Arginine Translocation pathway in bacteria to produce heterologous polypeptides that have multiple disulfide bonds. Methods of screening... |
|
|
US20100311059 |
GENDER-SPECIFIC SEPARATION OF SPERM CELLS AND EMBRYOS
Disclosed are sperm cells or embryos comprising a labeled oligonucleotide bound to a gender-specific repeat sequence. Methods for separating sperm cells or embryos containing a labeled... |
|
|
US20100311050 |
Compositions and methods for the diagnosis and treatment of tumor
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same. |
|
|
US20110038834 |
NOVEL AVIAN CYTOKINES AND GENETIC SEQUENCES ENCODING SAME
The present invention relates generally to novel recombinant polypeptides having avian cytokine properties and to genetic sequences encoding same. More particularly, the present invention is... |
|
|
US20050074805 |
Specific markers for diabetes
The present invention provides polypeptides which are correlated with pre-diabetes, diabetes or susceptibility to diabetes which can be used as markers for diagnosis of pre-diabetes, diabetes or a... |
|
|
US20100311069 |
MULTIPLEX CELL SIGNALLING ASSAYS
Disclosed are methods useful in multiplex cell-based assays for compound screening employing imaging instrumentation. The methods described herein offer high content information relating to the... |
|
|
US20070003947 |
Detecting genetic risk for periodontal disease
A method and kit for the identification of a user's genotypes associated with increased risk for developing periodontal disease are disclosed. The kit includes non-invasive DNA sample collecting... |
|
|
US20100184610 |
METHOD OF PROGNOSIS
Provided are methods, kits and arrays for use in determining susceptibility to keloid formation. These determine susceptibility based on comparison of gene expression in a patient of interest with... |
|
|
US20100298434 |
NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION
There is provided methods for the prevention of dopaminergic cell death for neuroprotection and the prevention or slow down of progression of Parkinson's disease. Particularly, the invention... |
|
|
US20110045992 |
DNA SEQUENCING METHOD AND SYSTEM
The present invention relates to the field of gene engineering, provides a DNA sequencing method and system. Said DNA sequencing method includes following steps: A. said DNA is processed into... |
|
|
US20090258360 |
METHOD OF DETECTING EQUINE POLYSACCHARIDE STORAGE MYOPATHY
The present invention relates to diagnosing Polysaccharide Storage Myopathy (PSSM) disease in equines. |
|
|
US20100303771 |
GABA NEURON PROGENITOR CELL MARKER 65B13
The present inventors identified a selective marker 65B13 for GABA neuron progenitor cells of the spinal dorsal horn and cerebellum, and successfully isolated GABA neuron progenitor cells using... |
|
|
US20110085980 |
CELL CYCLE REGULATION AND DIFFERENTIATION
The present invention provides compositions and methods for regulating neural cell proliferation or differentiation. The present invention also provides methods for selecting for bioactive agents... |
|
|
US20090092974 |
Micrornas differentially expressed in leukemia and uses thereof
The present invention concerns methods and compositions for identifying a miRNA profile for acute myeloid leukemia (AML), and using the profile in assessing the condition of a patient. |
|
|
US20100304987 |
METHODS AND KITS FOR DIAGNOSIS AND/OR PROGNOSIS OF THE TOLERANT STATE IN LIVER TRANSPLANTATION
The long-term survival of transplanted grafts critically depends on the life-long administration of immunosuppressive drugs to prevent graft rejection. These drugs are very effective at preventing... |
|
|
US20140086887 |
ADULT STEM CELL LINE INTRODUCED WITH HEPATOCYTE GROWTH FACTOR GENE AND NEUROGENIC TRANSCRIPTION FACTOR GENE WITH BASIC HELIX-LOOP-HELIX MOTIF AND USES THEREOF
The present invention relates to an adult stem cell line introduced with an HGF gene and a neurogenic transcription factor gene of a bHLH family, a preparation method of the adult stem cell line,... |
|
|
US20110020795 |
ANALYZING THE FMR1 GENE
A method of predicting a degree of risk of early ovarian aging of a young female. The method includes analyzing the female's FMR1 gene, wherein the FMR1 gene has a first allele and a second... |
|
|
US20100317010 |
ELF3 gene compositions and methods
ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5′ untranslated region, and a novel Alu, Alukwd. Methods and kits using primers or... |
|
|
US20070224599 |
INTERACTION OF STRESSFUL LIFE EVENTS AND A SEROTONIN TRANSPORTER POLYMORPHISM IN THE PREDICTION OF EPISODES OF MAJOR DEPRESSION
People with the SS variant of the human serotonin transporter gene are more susceptible to episodes of major depression when faced with mildly threatening life events than people with the SL or LL... |
|
|
US20110052488 |
Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis
Methods of identifying, diagnosing, and prognosing rheumatoid arthritis are provided, as well as methods of treating rheumatoid arthritis. Also provided are methods for identifying effective... |
|
|
US20100068718 |
Methods and Compositions for Identifying Yeast
The invention relates to a method of identifying a specific yeast species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the yeast species from... |
|
|
US20100311053 |
USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK
The use of the single nucleotide polymorphism (SNP) of the CLEC1B gene for the identification of cardiovascular and/or thrombotic disorders or of an increased risk for developing cardiovascular... |
|
|
US20090226887 |
Device for binding a target entity to a bait entity and detection methods using the same
The present invention pertains to a device for binding a target entity onto a bait entity that is immobilized on said device, comprising: a) a lipid layer having a negative net charge in an... |
|
|
US20100297636 |
CC2D2A GENE MUTATIONS ASSOCIATED WITH JOUBERT SYNDROME AND DIAGNOSTIC METHODS FOR IDENTIFYING THE SAME
The present invention provides a method of screening a subject for mutations in the CC2D2A gene that are associated with Joubert syndrome, an autosomal recessive form of mental retardation. The... |
|
|
US20130022988 |
YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR
Disclosed are yeast cells expressing a polypeptide comprising a signal sequence and a human amyloid beta protein. Also disclosed are methods of screening yeast cells to identify compounds that... |
|
|
US20110201519 |
Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject
Methods are provided for determining whether a subject has a graft tolerant phenotype. In practicing the subject methods, the expression of at least 5 genes in a sample from the subject, e.g., a... |
|
|
US20050170359 |
Treatment of vascular dysfunction and alzheimer's disease
Dysregulation of vascular function is observed in brain endothelium derived from patients affected by Alzheimer's disease. This may be manifested at the cell or organ level: e.g., abnormal... |
|
|
US20110045467 |
PERIPHERAL NEUROPATHY DIAGNOSIS
Genes whose expression is correlated with the presence of CIDP or vasculitic neuropathy are disclosed. Probes and sets of nucleic acid and proteins specific for these genes are described, as are... |
|
|
US20090130683 |
PREDICTING AND DIAGNOSING PATIENTS WITH AUTOIMMUNE DISEASE
The present invention provides methods for the prediction and diagnosis of autoimmune diseases, including Systemic Lupus Erythematosus, using single nucleotide polymorphism in TNFAIP3 (A20). |
|
|
US20110027787 |
METHODS AND SYSTEMS FOR IDENTIFYING AND ISOLATING STEM CELLS AND FOR OBSERVING MITOCHONDRIAL STRUCTURE AND DISTRIBUTION IN LIVING CELLS
Methods and systems for a) identifying and isolating stem cells, b) assessing mitochondrial distribution and structure in living cells and c) performing fluorescence microscopy on living cells... |
|
|
US20100304365 |
MUTATION OF PRPS1 GENE CAUSING CMTX5 DISEASE AND THE USE THEREOF
Disclosed is a gene mutation associated with peripheral neuropathy associated with sensorineural hearing loss and optic neuropathy. More specifically, disclosed are: a polynucleotide comprising a... |